S&P 500   4,550.43
DOW   35,333.47
QQQ   389.17
Is Microsoft the NVIDIA Killer? 
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
2 stocks that faded their price gaps after crushing earnings
Give up the OPEC fight with these 3 stocks, Buffett-certified
Important info on NVDA trade (Ad)
10-year yield is below 4.5%...these dividend growth yields aren’t
AI revolution: 3 stocks set to soar as technology evolves
Important info on NVDA trade (Ad)
Is there money hiding under these 2 mattress stocks?
3 reasons a squeeze could be in Paramount's coming attractions
S&P 500   4,550.43
DOW   35,333.47
QQQ   389.17
Is Microsoft the NVIDIA Killer? 
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
2 stocks that faded their price gaps after crushing earnings
Give up the OPEC fight with these 3 stocks, Buffett-certified
Important info on NVDA trade (Ad)
10-year yield is below 4.5%...these dividend growth yields aren’t
AI revolution: 3 stocks set to soar as technology evolves
Important info on NVDA trade (Ad)
Is there money hiding under these 2 mattress stocks?
3 reasons a squeeze could be in Paramount's coming attractions
S&P 500   4,550.43
DOW   35,333.47
QQQ   389.17
Is Microsoft the NVIDIA Killer? 
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
2 stocks that faded their price gaps after crushing earnings
Give up the OPEC fight with these 3 stocks, Buffett-certified
Important info on NVDA trade (Ad)
10-year yield is below 4.5%...these dividend growth yields aren’t
AI revolution: 3 stocks set to soar as technology evolves
Important info on NVDA trade (Ad)
Is there money hiding under these 2 mattress stocks?
3 reasons a squeeze could be in Paramount's coming attractions
S&P 500   4,550.43
DOW   35,333.47
QQQ   389.17
Is Microsoft the NVIDIA Killer? 
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
2 stocks that faded their price gaps after crushing earnings
Give up the OPEC fight with these 3 stocks, Buffett-certified
Important info on NVDA trade (Ad)
10-year yield is below 4.5%...these dividend growth yields aren’t
AI revolution: 3 stocks set to soar as technology evolves
Important info on NVDA trade (Ad)
Is there money hiding under these 2 mattress stocks?
3 reasons a squeeze could be in Paramount's coming attractions

Valens GroWorks Stock Price, News & Analysis (CVE:VGW)

C$3.10
+0.05 (+1.64%)
(As of 12/18/2019)
Today's Range
C$2.97
C$3.10
50-Day Range
C$3.10
C$3.10
52-Week Range
C$1.22
C$4.90
Volume
306,310 shs
Average Volume
622,710 shs
Market Capitalization
C$383.88 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

VGW Stock Price History

VGW Stock News Headlines

[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Important info on NVDA trade
Today, I’m pulling back the curtain on my all-new Everyday Income project. A way for everyday folks to target a couple hundred bucks or more every single day the markets are open… Without breaking a sweat!
Valens Co Inc/The
Valens GroWorks announces change in board of directors
Valens GroWorks rebrands to The Valens Company
Valens Groworks Enters Into LOI With Ross' Gold™
Valens GroWorks Corp earns Buy recommendation from Power Growth Investor
See More Headlines
Receive VGW Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Valens GroWorks and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
N/A
Sub-Industry
N/A
Sector
N/A
CIK
N/A
Web
N/A
Phone
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$27.50 million
Cash Flow
C$0.57 per share
Book Value
C$0.98 per share

Miscellaneous

Free Float
N/A
Market Cap
C$383.88 million
Optionable
Not Optionable
Beta
N/A
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report














VGW Stock Analysis - Frequently Asked Questions

How have VGW shares performed in 2023?

Valens GroWorks' stock was trading at C$3.10 at the beginning of the year. Since then, VGW stock has increased by 0.0% and is now trading at C$3.10.
View the best growth stocks for 2023 here
.

What other stocks do shareholders of Valens GroWorks own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Valens GroWorks investors own include Organigram (OGI), Green Organic Dutchman (TGOD), Aurora Cannabis (ACB), BlackBerry (BB), Dynavax Technologies (DVAX), Heat Biologics (HTBX), Drone Delivery Canada (TAKOF), VEON (VEON) and Vaxart (VXRT).

How do I buy shares of Valens GroWorks?

Shares of VGW stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

This page (CVE:VGW) was last updated on 11/28/2023 by MarketBeat.com Staff

My Account -